Literature DB >> 31135426

Tofacitinib Trial Prompts FDA Review of Adverse Effects.

Diane S Aschenbrenner1.   

Abstract

Entities:  

Year:  2019        PMID： 31135426     DOI： 10.1097/01.NAJ.0000559803.24361.5e

Source DB:  PubMed          Journal:  Am J Nurs        ISSN： 0002-936X            Impact factor:   2.220


× No keyword cloud information.
  1 in total

Review 1.  A Comprehensive Overview of Globally Approved JAK Inhibitors.

Authors:  Ahmed M Shawky; Faisal A Almalki; Ashraf N Abdalla; Ahmed H Abdelazeem; Ahmed M Gouda
Journal:  Pharmaceutics       Date:  2022-05-06       Impact factor: 6.525
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.